XOMA ROYALTY CORPORATION

Analyst Reco. XOMA Royalty Corporation

Equities

XOMA

US98419J2069

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-11 pm EDT			5-day change	1st Jan Change
26.18 ^USD	+1.95%		+1.08%	+41.51%

Jul. 09	Xoma Changes Name to Xoma Royalty	MT
Jul. 01	XOMA Corporation(NasdaqGM:XOMA) added to Russell 3000 Growth Index	CI

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Leerink Partners Starts XOMA With Outperform Rating, $40 Price Target	Apr. 29	MT
HC Wainwright Adjusts Price Target on XOMA to $74 From $69, Maintains Buy Rating	23-08-09	MT
XOMA : Wedbush Suspended Coverage on XOMA	21-10-11	MT
XOMA : HC Wainwright Adjusts XOMA's Price Target to $69 from $56, Keeps Buy Rating	21-10-08	MT
XOMA : Aegis Capital Adjusts XOMA Price Target to $56 From $60, Maintains Buy Rating	21-09-09	MT
Wedbush Downgrades XOMA to Neutral From Outperform, Adjusts PT to $22 From $41	21-09-07	MT
XOMA : Wedbush Downgrades XOMA to Neutral From Outperform, Adjusts PT to $22 From $41	21-09-07	MT
XOMA : Aegis Capital Starts XOMA at Buy with $20.68 Price Target	21-06-29	MT
XOMA : Wedbush Adjusts XOMA's Price Target to $41 From $36, Citing Iscalimab, Cetrelimab Projections; Outperform Rating Kept	21-03-19	MT
XOMA : Wedbush Adjusts XOMA's Price Target to $36 From $29 on Vicineum Sales Forecast, Keeps Outperform Rating	20-11-27	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Secure my Investments

fermer